MDxHealth Investor Relations Material
Latest events
Q1 2025
MDxHealth
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from MDxHealth SA
Access all reports
MDxHealth SA is a molecular diagnostics company focused on the development and commercialization of genomic tests for cancer. Specializing in urologic oncology, the company provides non-invasive tests that assist in the diagnosis and management of prostate and bladder cancers. MDxHealth’s tests use epigenetic and genetic markers to deliver accurate, personalized insights that support healthcare providers in making informed treatment decisions. The company is headquartered in Herstal, Belgium, and its shares are listed on the Euronext Brussels and the Nasdaq.
Key slides for MDxHealth SA
Q3 2024
MDxHealth SA
Q3 2024
MDxHealth SA
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
MDXH
Country
🇺🇸 United States